Skip to main content
Premium Trial:

Request an Annual Quote

Qiagen Gets $600K From US DoD to Ramp up COVID-19 Test Kit, Reagent Manufacturing

NEW YORK – The US Department of Defense said on Monday that it has awarded a $600,000 contract to Qiagen to expand manufacturing capacity of enzymatic reagents and reagent kits used in COVID-19 molecular diagnostic tests.

The contract, awarded on behalf of and in conjunction with the US Department of Health and Human Services, will allow Qiagen to increase its monthly production of reagent kits by 7,000 and enzymes by 5,100 milligrams in its Beverly, Massachusetts, facility by the end of February 2022 to support domestic laboratory testing for COVID-19.

The current manufacturing capacity of Qiagen's Beverly facility is unknown. An email to the company was not immediately returned.

The DoD's Defense Assisted Acquisition Cell, or DA2, led this effort in coordination with the Department of the Air Force's Acquisition COVID-19 Task Force, or DAF ACT.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.